Skip to main content
SpringerLink
Log in

Magnesium and Hypertension

  • Chapter
  • First Online:
Magnesium in Human Health and Disease

Part of the book series: Nutrition and Health ((NH))

Abstract

Hypertension remains the leading cause of cardiovascular disease (CVD) affecting approximately one billion individuals worldwide [1]. More than 72 million Americans, or nearly one in three adults, are estimated to have high blood pressure (BP), but only 35 % reach goal BP control [2]. Nearly 70 million more adults are at risk of developing prehypertension, and 90 % of adults will probably develop high BP by age 65 [3]. Hypertension is associated with an increased risk of morbidity and mortality from cerebrovascular accidents (CVA), coronary heart disease (CHD), congestive heart failure (CHF), and end-stage renal disease (ESRD). Over the past several years, there has been little change in BP diagnostic thresholds, treatment targets, or in treatment approaches. Due to its high prevalence, hypertension remains the most common reason for visits to physician’s offices and the primary reason for prescription drug use.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Israili ZH, Hernandez-Hernandez R, Valasco M. The future of antihypertensive treatment. Am J Ther. 2007;14:121–34.

    Article  PubMed  Google Scholar 

  2. Rosamund W. Heart disease and stroke-2008 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;17(4):e25.

    Google Scholar 

  3. Svetkey LP, Simons-Morton DG, Proschan MA. Effect of the dietary approaches to stop hypertension diet and reduced sodium intake on blood pressure control. J Clin Hypertens. 2004;6:373–81.

    Article  Google Scholar 

  4. Young DB, Lin H, McCabe RD. Potassium’s cardiovascular protective mechanisms. Am J Physiol. 1995;268(4 part 2):R825–37.

    PubMed  CAS  Google Scholar 

  5. INTERSALT Cooperative Research Group. INTERSALT: an international study of electrolyte excretion and blood pressure. Results for 24 hr urinary sodium and potassium excretion. BMJ. 1988;297:319–28.

    Article  Google Scholar 

  6. Efford J, Philips A, Thomsoon AG. Migration and geographic variations in blood pressure in Britain. BMJ. 1990;300:291–5.

    Article  Google Scholar 

  7. Appel LJ, Moore TH, Obarzanek E. A clinical trial of the effects of dietary patterns on blood pressure. Research Group. N Engl J Med. 1997;336:1117–24.

    Article  PubMed  CAS  Google Scholar 

  8. Sacks FM, Svetkey LP, Vollmer WM, DASH-Sodium Collaborative Research Group. Effects on blood pressure or reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med. 2001;344:3–10.

    Article  PubMed  CAS  Google Scholar 

  9. Moore TJ, Conlin PR, Ard J. DASH (Dietary Approaches to Stop Hypertension) diet is effective treatment for stage 1 isolated systolic hypertension. Hypertension. 2001;38:155–8.

    Article  PubMed  CAS  Google Scholar 

  10. Chobanian AV, et al. The seventh report of the joint National Committee on prevention, detection, evaluation and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560–72.

    Article  PubMed  CAS  Google Scholar 

  11. Appel LJ, Brands ME, Daniels SR. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension. 2006;47:296–308.

    Article  PubMed  CAS  Google Scholar 

  12. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011–63.

    Article  Google Scholar 

  13. Whitworth JA, World Health Organization. International Society of Hypertension Writing Group. 2003 World Health Organization (WHO) International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21(11):1983–92.

    Article  PubMed  Google Scholar 

  14. Williams B, Poulter NR, Brown MJ. British Hypertension Society guidelines for hypertension management. 2004(BHS -IV): summary. BMJ. 2004;328:634–40.

    Article  PubMed  Google Scholar 

  15. Jee SH, Miller ER, Guallar E. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens. 2002;15:691–6.

    Article  PubMed  CAS  Google Scholar 

  16. Touyz RM. Role of magnesium in the pathogenesis of hypertension. Mol Aspects Med. 2003;24:107–36.

    Article  PubMed  CAS  Google Scholar 

  17. Resnick LM. Magnesium in the pathophysiology and treatment of hypertension and diabetes mellitus. Where are in 1997? Am J Hypertens. 1997;10:368–70.

    Article  PubMed  CAS  Google Scholar 

  18. Kawano Y, Matsuoka H, Takishita S, Omae T. Effects of magnesium supplementation in hypertensive patients: assessment by office, home, and ambulatory blood pressures. Hypertension. 1998;32:260–5.

    Article  PubMed  CAS  Google Scholar 

  19. Witteman JC, Grobbee DE, Derkx FH, Bouillon R, de Bruijn AM, Hofman A. Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension. Am J Clin Nutr. 1994;60(1):129–35.

    PubMed  CAS  Google Scholar 

  20. Hatzistavri LS, Sarafidis PA, Georgianos PI, Tziolas IM, Aroditis CP, Zebekakis PE, et al. Oral magnesium supplementation reduces ambulatory blood pressure in patients with mild hypertension. Am J Hypertens. 2001;22(10):1070–5.

    Article  Google Scholar 

  21. Sacks FM, Brown LE, Appel L. Combination of potassium, calcium and magnesium supplements in hypertension. Hypertension. 1995;26(6 part 1):950–6.

    Article  PubMed  CAS  Google Scholar 

  22. Mizushima S, Cuppauccio FP, Nichols R. Dietary magnesium intake and blood pressure: a qualitative overview of the observational studies. J Hum Hypertens. 1998;12:447–53.

    Article  PubMed  CAS  Google Scholar 

  23. Dickinson HO, Nicolson DJ, Campbell F. Potassium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev. 2006;3:CD004641.

    PubMed  Google Scholar 

  24. Haga H. Effects of dietary magnesium supplementation on diurnal variations of blood pressure and plasma Na+, K  +  − ATPase activity in essential hypertension. Jpn Heart J. 1992;33(6):785–800.

    Article  PubMed  CAS  Google Scholar 

  25. Kisters K. Oral magnesium supplementation improves borderline hypertension. Magnes Res. 2011;24:17–8.

    PubMed  CAS  Google Scholar 

  26. Patki PS, SIngh J, Gokhale SV, Bulakh PM, Shrotri DS, Patwardhan B. Efficacy of potassium and magnesium in essential hypertension: a double-blind placebo controlled, crossover study. BMJ. 1990;301:521–3.

    Article  PubMed  CAS  Google Scholar 

  27. Houston MC. The importance of potassium in managing hypertension. Curr Hypertens Rep. 2011;13(4):309–17.

    Article  PubMed  CAS  Google Scholar 

  28. McCarty MF. Complementary vascular-protective actions of magnesium and taurine: a rationale for magnesium taurate. Med Hypothesis. 1996;46(2):89–100.

    Article  CAS  Google Scholar 

  29. Yamori Y, Taquchi T, Mori H, Mori M. Low cardiovascular risks in the middle aged males and females excreting greater 24-hour urinary taurine and magnesium in 41 WHO-CARDIAC study populations in the world. J Biomed Sci. 2010;17 Suppl 1:S 21.

    Google Scholar 

  30. Guerrero-Romero F, Rodriquez-Moran M. The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind placebo-controlled clinical trial. J Hum Hypertens. 2009;23(4):245–51.

    Article  PubMed  CAS  Google Scholar 

  31. Rosanoff A. Magnesium supplements may enhance the effect of antihypertensive medication in stage 1 hypertensive subjects. Magnes Res. 2010;23(1):27–40.

    PubMed  CAS  Google Scholar 

  32. Wirell MP, Wester PO, Steqmayr BG. Nutritional dose of magnesium in hypertensive patients on beta blockers lowers systolic blood pressure: a double-blind, cross-over study. J Intern Med. 1994;236(2):189–95.

    Article  PubMed  CAS  Google Scholar 

  33. Rudnicki M, Frolich A, Pilagaard K, Nymbereg L, Moller M, Sanchez M, et al. Comparison of magnesium and methyldopa for the control of blood pressure in pregnancies complicated with hypertension. Gynecol Obstet Invest. 2000;49(2):231–5.

    Article  PubMed  CAS  Google Scholar 

  34. Larsson SC, Virtamo J, Wolk A. Potassium, calcium and magnesium intakes and risk of stroke in women. Am J Epidemiol. 2011;174(1):35–43. Epub 2011 May 3.

    Article  PubMed  Google Scholar 

  35. Raffelmann T, Dorr M, Ittermann TM, Schwahn C, Volzke H, Ruppert J, et al. Low serum magnesium concentrations predicts increase in left ventricular mass over 5 years independently of common cardiovascular risk factors. Atherosclerosis. 2010;213:563–9.

    Article  Google Scholar 

  36. Ohira T, Peacock JM, Iso H, Chambless LE, Rosamond WD, Folsom AR. Serum and dietary magnesium and risk of ischemic stroke: the Atherosclerosis risk in communities study. Am J Epidemiol. 2009;169(12):1437–44.

    Article  PubMed  Google Scholar 

  37. Champagne CM. Magnesium in hypertension, cardiovascular disease, metabolic syndrome and other conditions: a review. Nutr Clin Pract. 2008;23:142–51.

    Article  PubMed  Google Scholar 

  38. Hadjistavri LS, Sarafidis PA, Georgianos PI, Tziolas IM, Aroditis CP, Hitoglou-Makedou A, et al. Beneficial effects of oral magnesium supplementation on insulin sensitivity and serum lipid profile. Med Sci Monit. 2010;16:CR 307–12.

    CAS  Google Scholar 

  39. Khan AM, Sullivan L, Mccabe E, Levy D, Vasan RS, Want TJ. Lack of association between serum magnesium and the risks of hypertension and cardiovascular disease. Am Heart J. 2010;160:715–20.

    Article  PubMed  CAS  Google Scholar 

  40. Barbagallo M, Dominguez LJ, Galioto A, Pineo A, Belvedere M. Oral magnesium supplementation improves vascular function in elderly diabetic patients. Magnes Res. 2010;23:131–7.

    PubMed  CAS  Google Scholar 

  41. Preuss HG. Diet, genetics and hypertension. J Am Coll Nutr. 1997;16:296–305.

    PubMed  CAS  Google Scholar 

  42. Das UN. Essential fatty acids: biochemistry, physiology and pathology. Biotechnol J. 2006;1(4):420–39.

    Article  PubMed  CAS  Google Scholar 

  43. Un D. Nutrients, essential fatty acids and prostaglandins interact to augment immune responses and prevent genetic damage and cancer. Nutrition. 1989;5:106–10.

    Google Scholar 

  44. Das UN. Delta 6 desaturase as the target of the beneficial actions of magnesium. Med Sci Monit. 2010;16(8):LE11–2.

    PubMed  Google Scholar 

  45. Sonita B, Touyz RM. Magnesium transport in hypertension. Pathophysiology. 2007;14:205–11.

    Article  Google Scholar 

  46. Kisters K, Gremmler B, Hausberg M. Disturbed Mg++ transporters in hypertension. J Hypertens. 2008;26:2450–1.

    Article  PubMed  CAS  Google Scholar 

  47. Yogi A, Callera GE, Antuens TT, Tostes RC, Touyz RM. Vascular biology of magnesium and its transporters in hypertension. Magnes Res. 2010;23(4):207–15.

    Google Scholar 

  48. Yoga A, Callera GE, Antunes TT, Tostes RC, Touyz RM. Transient receptor potential melastatin 7 (TRPM7) cation channels, magnesium and the vascular system in hypertension. Circ J. 2011;75:237–45.

    Article  Google Scholar 

  49. Trapani V, Farruggia G, Marraccini C, Iotti S, Cittadine A, Wolf FL. Intracellular magnesium detection: imaging a brighter future. Analyst. 2010;135:1855–66.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Vanderbilt University School of Medicine, 4230 Harding Road, Suite 400, Nashville, 37205, TN, USA

    Mark Houston M.D., M.S., FACP, FAHA, FASH (Associate Clinical Professor, Director)

  2. Department of Medicine, Hypertension Institute, Saint Thomas Hospital, 4230 Harding Road, Suite 400, Nashville, 37205, TN, USA

    Mark Houston M.D., M.S., FACP, FAHA, FASH (Associate Clinical Professor, Director)

Authors
  1. Mark Houston M.D., M.S., FACP, FAHA, FASH
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark Houston M.D., M.S., FACP, FAHA, FASH .

Editor information

Editors and Affiliations

  1. Arizona Health Science Center, Mel and Enid Zuckerman, University of Arizona, 1295 N. Martin, Tucson, 85724-5155, Arizona, USA

    Ronald Ross Watson

  2. Dept. Nutrition & Dietetics, King's College, Stamford St. 150, London, SE1 9NH, United Kingdom

    Victor R. Preedy

  3. Division of Health Promotion Sciences, Mel and Enid Zuckerman, University of Arizona, 1295 N. Martin Avenue, Tucson, 85724, Arizona, USA

    Sherma Zibadi

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Houston, M. (2013). Magnesium and Hypertension. In: Watson, R., Preedy, V., Zibadi, S. (eds) Magnesium in Human Health and Disease. Nutrition and Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-044-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-044-1_12

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-043-4

  • Online ISBN: 978-1-62703-044-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation